Considering the Role of Medication in Early Childhood Mental Health
Dr. Mary Margaret Gleason addresses the factors to consider in the role of psychopharmacologic treatment as a part of an early childhood mental health treatment plan.
This two-day presentation will address the factors to consider in the role of psychopharmacologic treatment as a part of an early childhood mental health treatment plan, with attention to the emotional reactions to the topic, prescribing patterns, developmental differences in young children compared to older children, the database, and approaches to the clinical questions.
On the first afternoon, Dr. Gleason will consider the impact of medical issues on infant and early childhood mental health and the roles of pediatricians.
On the second afternoon, she will focus on medication and what non-prescribing clinicians need to know.
*Approved for 6 CEU’s* for Social Work, Mental Health Counseling, Marriage & Family Therapists, Psychology (and Education at school discretion) Workshops meet at least six of the competencies for Infant Mental Health Endorsement.
- 12/03/20 from 2:00 p.m. – 5:00 p.m.
- 12/10/20 from 2:00 p.m. – 5:00 p.m.
Group Rates: Agencies sending 6 or more staff to this workshop are eligible for a Group Rate.
Please inquire for larger groups by emailing firstname.lastname@example.org.
About the Presenter
Mary Margaret Gleason, MD
Dr. Gleason is trained as a pediatrician and child and adolescent psychiatrist and has special interests in early childhood mental health and the integration of mental health services into primary care. She trained at Brown University in a triple board residency and completed an infant mental health fellowship at Tulane, where she has been on faculty since 2003. She is particularly interested in the early identification of children at risk for mental health problems and has developed and validated a screen for use in pediatric primary care. She led the development of practice guidelines for a task force in the American Academy of Child and Adolescent Psychiatry and the recently published American Academy of Pediatrics guidelines. She is honored to sit on the boards of Zero to Three and the National Association of Child Psychiatry Access Programs.
For more information regarding this event, please contact: